All Relations between Tuberous Sclerosis and ds

Publication Sentence Publish Date Extraction Date Species
Michael LoPresti, Ataru Igarashi, Yaoki Sonohara, Sally Bowditc. A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan. Epilepsy & behavior : E&B. vol 154. 2024-03-31. PMID:38555725. lennox-gastaut syndrome (lgs), dravet syndrome (ds), and tuberous sclerosis complex (tsc)-associated epilepsy are rare conditions associated with severe childhood-onset epilepsy. 2024-03-31 2024-04-03 Not clear
Jingyi Tong, Tingting Ji, Ting Liu, Jiaqi Liu, Yibin Chen, Zongjun Li, Na Lu, Qifu L. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis. Epilepsy & behavior : E&B. vol 152. 2024-01-26. PMID:38277848. this study aimed to evaluate the efficacy and safety of six new antiseizure medications (asms) for adjunctive treatment in adult patients with focal epilepsy and adolescents with dravet syndrome (ds), lennox-gastaut syndrome (lgs), or tuberous sclerosis complex (tsc). 2024-01-26 2024-01-29 Not clear
M Perriguey, M El Succar, A Clément, S Lagarde, O Ribes, X Dode, S Rheims, F Bartolome. High-purified cannabidiol efficacy and safety in a cohort of adult patients with various types of drug-resistant epilepsies. Revue neurologique. 2023-10-08. PMID:37806886. lennox-gastaut syndrome (lgs), dravet syndrome (ds) and tuberous sclerosis complex (tsc) are diseases for which high-purified-cannabidiol (cbd) known as epidiolex® (gw pharma) can be prescribed in add-on of other medications in case of drug-resistance. 2023-10-08 2023-10-15 Not clear
Darina Georgieva, James Langley, Katherine Hartkopf, Lisa Hawk, Amanda Margolis, Aaron Struck, Elizabeth Felton, David Hsu, Barry E Gida. Real-world, long-term evaluation of the tolerability and therapy retention of Epidiolex® (cannabidiol) in patients with refractory epilepsy. Epilepsy & behavior : E&B. vol 141. 2023-03-09. PMID:36893722. epidiolex® (cbd) is fda-approved for seizures associated with lennox-gastaut syndrome (lgs), dravet syndrome (ds), and tuberous sclerosis complex (tsc). 2023-03-09 2023-08-14 Not clear
Fabienne Kühne, Lena-Luise Becker, Thomas Bast, Astrid Bertsche, Ingo Borggraefe, Christian Malte Boßelmann, Jörg Fahrbach, Christoph Hertzberg, Nina A Herz, Martin Hirsch, Martin Holtkamp, Christine Janello, Gerhard Josef Kluger, Gerhard Kurlemann, Holger Lerche, Konstantin L Makridis, Felix von Podewils, Milka Pringsheim, Susanne Schubert-Bast, Juliane Schulz, Andreas Schulze-Bonhage, David Steinbart, Bernhard J Steinhoff, Adam Strzelczyk, Steffen Syrbe, Heike De Vries, Christiane Wagner, Johanna Wagner, Bernd Wilken, Christine Prager, Kerstin A Klotz, Angela M Kaind. Real world data on cannabidiol treatment of various epilepsy subtypes: a retrospective, multicenter study. Epilepsia open. 2023-01-24. PMID:36693811. cannabidiol (cbd) is approved for treatment of dravet syndrome (ds), lennox-gastaut syndrome (lgs), and tuberous sclerosis complex (tsc). 2023-01-24 2023-08-14 Not clear
Gabriele Ruffolo, Alessandro Gaeta, Beatrice Cannata, Camilla Pinzaglia, Eleonora Aronica, Alessandra Morano, Pierangelo Cifelli, Eleonora Palm. GABAergic Neurotransmission in Human Tissues Is Modulated by Cannabidiol. Life (Basel, Switzerland). vol 12. issue 12. 2022-12-23. PMID:36556407. among the different pcbs, cannabidiol (cbd) has showed interesting biological properties, making it a promising molecule with a high security profile that has been approved for treatment as an add-on therapy in patients afflicted by severe pharmaco-resistant epilepsy, including dravet syndrome (ds), lennox-gastaut syndrome (lgs) and tuberous sclerosis complex (tsc). 2022-12-23 2023-08-14 human
Ashna Talwar, Emily Estes, Rajender Aparasu, Doodipala Samba Redd. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Experimental neurology. 2022-10-07. PMID:36206805. in this study, we evaluated the overall clinical potential of oral cbd to treat refractory epilepsy in patients with dravet syndrome (ds), lennox-gastaut syndrome (lgs), and tuberous sclerosis complex (tsc) through a systematic review and meta-analysis. 2022-10-07 2023-08-14 Not clear
Kishan Vyas, Hannah Luedke, Benjamin Ruban-Fel. Nordic treatment guidelines for rare epileptic conditions: A literature review. Brain and behavior. 2022-06-29. PMID:35765698. the onset of severe, drug-resistant seizures in early childhood is characteristic of the rare epileptic disorders lennox-gastaut syndrome (lgs), dravet syndrome (ds), and cdkl5 deficiency disorder (cdd) and is frequently observed in the rare genetic conditions tuberous sclerosis complex (tsc) and rett syndrome (rtt). 2022-06-29 2023-08-14 Not clear
b' Val\\xc3\\xa9rie C\\xc3\\xb4t\\xc3\\xa9, \\xc3\\x88ve Lalancette, Inga S Knoth, Lucie C\\xc3\\xb4t\\xc3\\xa9, Kristian Agbogba, Phetsamone Vannasing, Philippe Major, Fanny Barlaam, Jacques Michaud, Sarah Lipp\\xc3\\xa. Distinct patterns of repetition suppression in Fragile\\xc2\\xa0X\\xc2\\xa0syndrome, down syndrome, tuberous sclerosis complex and mutations in SYNGAP1. Brain research. vol 1751. 2021-11-30. PMID:33189692.' one hundred and five participants, aged between 3 and 30 years old, composing four clinical id groups and one control group, were recruited: fragile x syndrome (fxs; n = 14), tuberous sclerosis complex (tsc; n = 9), down syndrome (ds; n = 19), syngap1 mutations (n = 8) and neurotypical controls (nt; n = 55)). 2021-11-30 2023-08-13 human
Nancy L Reaven, Susan E Funk, Paul D Lyons, Tyler J Stor. The direct cost of seizure events in severe childhood-onset epilepsies: A retrospective claims-based analysis. Epilepsy & behavior : E&B. vol 93. 2020-06-23. PMID:30831405. lennox-gastaut syndrome (lgs), dravet syndrome (ds), and tuberous sclerosis complex (tsc) are representative conditions associated with frequent intractable seizures. 2020-06-23 2023-08-13 Not clear